Investments

Buyout

GBA Group

Germany

28 April 2021

Healthcare & life science

Healthcare & life science

GBA Group is a leading independent provider of highest-quality bio-analytical laboratory services for food, environment, and pharmaceutical testing. The group focuses on tailor-made solutions to meet its clients’ needs, backed by its strong scientific expertise, very comprehensive service portfolio as well as continuous dialogue with its customers. Headquartered in Hamburg, GBA employs well over 1,000 employees and operates more than 40 labs across central Europe.

Deal team

Alexander Friedrich

Gunnar Chrestin

Philipp Lattermann

Christian Koch

Press releases

Ardian acquires a majority stake in GBA Group, a leading bio-analytical laboratory services provider, alongside GBA Group’s management team and Quadriga Capital

https://www.gba-group.com/

https://twitter.com/GBAGroupPharma

https://www.linkedin.com/company/gbagroup/

We appreciate Ardian’s unique support on our growth path that helped us very much to become market leader and position us ideally for future growth.”

Daniel Schustermann Managing Director of Schustermann & Borenstein

It is an efficient team, determined and confident in its choices, and always attentive to its partners. The relationships of trust that the Ardian team builds over time, with the management teams and, beyond that, with the advisors around them, are part of their DNA.

David Aknin Lawyer

Buyout

Expertise
Buyout

Team

Investments

GBA Group

Deal team

Press releases